| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Camptothecin | GDSC1000 | pan-cancer | AAC | -0.065 | 0.05 |
| mRNA | fingolimod | CTRPv2 | pan-cancer | AAC | 0.069 | 0.05 |
| mRNA | SN-38 | GDSC1000 | pan-cancer | AAC | -0.063 | 0.05 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | 0.084 | 0.05 |
| mRNA | CI-976 | CTRPv2 | pan-cancer | AAC | 0.074 | 0.05 |
| mRNA | HG-6-64-1 | GDSC1000 | pan-cancer | AAC | -0.064 | 0.05 |
| mRNA | GW-405833 | CTRPv2 | pan-cancer | AAC | -0.064 | 0.06 |
| mRNA | (5Z)-7-Oxozeaenol | GDSC1000 | pan-cancer | AAC | -0.057 | 0.06 |
| mRNA | fluvastatin | CTRPv2 | pan-cancer | AAC | -0.068 | 0.06 |
| mRNA | Midostaurin | GDSC1000 | pan-cancer | AAC | 0.064 | 0.06 |